FOLR1 and cancer: Designing CAR-T cells that can differentiate between cancer cells and cancer-free cells is essential to lower the risk of harm, apart from looking for antigens with limited expression on normal cells like folate receptor 1 (FOLR1) and tumor-associated glycoprotein 72 (TAG72) [67,68].